| 发明名称 | Prognostic signature for colorectal cancer recurrence | ||
| 摘要 | An assay system is useful for predicting recurrence and/or non-recurrence of colorectal cancer in a patient. The assay system is adapted to analyze a patient sample for quantitative expression of a prognostic genetic profile correlated with colorectal cancer recurrence. The profile includes the expression of the nucleic acid sequences of SEQ ID NOS: 1, 2, 3, 4, and 5. | ||
| 申请公布号 | US9234245(B2) | 申请公布日期 | 2016.01.12 |
| 申请号 | US201213351485 | 申请日期 | 2012.01.17 |
| 申请人 | Everist Genomics, Inc. | 发明人 | Worzel William P.;Lenehan Peter F.;Almal Arpit;Fry David W. |
| 分类号 | C07H21/04;C07H21/02;C12Q1/68 | 主分类号 | C07H21/04 |
| 代理机构 | Dykema Gossett PLLC | 代理人 | Dykema Gossett PLLC |
| 主权项 | 1. A kit or assay system for determining risk of colorectal cancer recurrence, the kit or assay system consisting of a set of cDNA molecules, wherein the set of cDNA molecules consists of: (i) a cDNA molecule consisting of the nucleotide sequence of SEQ ID NO: 1; (ii) a cDNA molecule consisting of the nucleotide sequence of SEQ ID NO: 2; (iii) a cDNA molecule consisting of the nucleotide sequence of SEQ ID NO: 3; (iv) a cDNA molecule consisting of the nucleotide sequence of SEQ ID NO: 4; and (v) a cDNA molecule consisting of the nucleotide sequence of SEQ ID NO: 5. | ||
| 地址 | Ann Arbor MI US | ||